People: WuXi Pharmatech (Cayman) Inc (WX)


WX on New York Consolidated

21.45USD
19 Jun 2013
Price Change (% chg)

$0.06 (+0.28%)
Prev Close
$21.39
Open
$21.45
Day's High
$21.65
Day's Low
$21.31
Volume
303,472
Avg. Vol
350,986
52-wk High
$21.84
52-wk Low
$13.00

Search Stocks

Summary

Name Age Since Current Position

Ge Li

 45 2004 Chairman of the Board, Chief Executive Officer

Edward Hu

 49 2010 Chief Financial Officer, Chief Operating Officer

Xiaozhong Liu

 48 2005 Executive Vice President, Director

Shuhui Chen

 48 2004 Chief Scientific Officer

Yifeng Shi

 45 2011 Vice President - Operations and Head of Waigaoqiao Site, Compliance officer, China

Zhaohui Zhang

 42 2005 Vice President - Domestic Marketing, Director

Suhan Tang

 46 2007 Chief Manufacturing Officer

Ning Zhao

 45 2009 Director

Ying Han

 58 2008 Independent Director

Stewart Hen

 46 2009 Independent Director

Xuesong Leng

 43 2008 Independent Director

Kian-Wee Seah

 49 2005 Independent Director

Ronald Aldridge

 IR Contact
» Insider Trading

Biographies

Name Description

Ge Li

 Dr. Ge Li, Ph.D., is Chairman of the Board, Chief Executive Officer of WuXi Pharmatech (Cayman) Inc. He has served as Chief Executive Officer since the Company was founded in 2000 and as Chairman since early 2004. Dr. Li is one of the founders of company. He is responsible for operations, strategic planning and business development. He was one of the founding scientists of Pharmacopeia, Inc. He received a bachelor’s degree in chemistry from Peking University and a master’s degree and a Ph.D. in organic chemistry from Columbia University.

Edward Hu

 Mr. Edward Hu is Chief Financial Officer and Chief Operating Officer of WuXi PharmaTech (Cayman) Inc. He has served as Chief Operating Officer since January 2008. Mr. Hu joined company in August 2007 and served as Executive Vice President of Operations before becoming Chief Operating Officer. He served as acting Chief Financial Officer from February 2009 to April 2010 and in August 2010 was reappointed to that position. From October 2000 to July 2007, he worked for Tanox, Inc., where he served as Senior Vice President and Chief Operating Officer. From 1998 to 2000, he worked for Biogen (now known as Biogen Idec) as Manager of Financial Planning and Analysis. From 1996 to 1998, he worked at Merck as a Senior Financial Analyst. He received his MBA and completed his Ph.D. work, except for his dissertation, in biophysics and biochemistry at Carnegie Mellon University.

Xiaozhong Liu

 Mr. Xiaozhong Liu is Executive Vice President and Director of WuXi PharmaTech (Cayman) Inc. He has served as Executive Vice President since 2001 and as a director since 2005. Mr. Liu is one of the founders of company. He is responsible for project and engineering departments. Mr. Liu received a bachelor’s degree from Peking University and an EMBA from China Europe International Business School.

Shuhui Chen

 Dr. Shuhui Chen is Chief Scientific Officer of WuXi PharmaTech (Cayman) Inc. Dr. Chen has served as Chief Scientific Officer since 2004. Dr. Chen’s main responsibilities include overseeing laboratory services segment in China. From 1998 to 2004, he worked for Eli Lilly as a Research Advisor. From 1995 to 1997, he worked for Vion Pharmaceuticals as a Group Leader and later as an Associate Director of Chemistry on several anti-cancer and anti-viral projects. From 1990 to 1995, he worked for Bristol-Myers Squibb as a Research Investigator and later as a Senior Research Investigator. Dr. Chen received a bachelor’s degree in chemistry from Fudan University and a Ph.D. in organic chemistry from Yale University.

Yifeng Shi

 Mr. Yifeng Shi is Vice President - Operations and Head of Waigaoqiao Site, Compliance officer, China of WuXi Pharmatech (Cayman) Inc. Mr. Shi has served as Vice President of Operations and Head of Waigaoqiao Site since August 2009. Mr. Shi has also served as Compliance Officer of WuXi AppTec China Region since August 2011. He joined the Company in 2002 and has served as Director, Senior Director and Executive Director of Chemistry. He has 19 years of experience in organic synthesis. From 1989 to 1998, Mr. Shi worked at Shanghai Institute of Organic Chemistry as a Scientist. From 1998 to 2002, he worked at GL Synthesis as a Research Scientist. Mr. Shi received a bachelor’s degree in chemistry from Shanghai University of Science and Technology.

Zhaohui Zhang

 Mr. Zhaohui Zhang is Vice President - Domestic Marketing and Director of WuXi PharmaTech (Cayman) Inc. He has served as Vice President of Domestic Marketing since 2002 and a director since 2005. Mr. Zhang is one of the founders of company. He is currently Senior Vice President of Operations and responsible for domestic marketing. Prior to joining company, he worked for Jiangsu Silver Bell Group as an Assistant to the General Manager and later as a Vice President of American Silver Bell Company responsible for government procurement. Mr. Zhang received a bachelor’s degree in mechanical and electrical engineering from Jiangnan University.

Suhan Tang

 Dr. Suhan Tang is Chief Manufacturing Officer of WuXi PharmaTech (Cayman) Inc. Dr. Tang has served as Chief Manufacturing Officer since 2007. Dr. Tang’s main responsibilities include overseeing manufacturing services segment. From 2003 to 2006, he was Vice President of Process Research and Development. From 1996 to 2003, he worked for Schering-Plough as a Principal Scientist. Dr. Tang received a bachelor’s degree in chemistry from Jilin University and a master’s degree and a Ph.D. in organic chemistry from Columbia University.

Ning Zhao

 Dr. Ning Zhao, Ph.D., is Director of WuXi PharmaTech (Cayman) Inc., since February 2009. Dr. Zhao, one of company’s co-founders , is currently Senior Vice President of Operations and Head of Corporate Human Resources. She was Vice President of the company’s analytical services department from 2004 to 2008 and also established its bioanalytical services, core analytical services and analytical development services departments. Dr. Zhao has previously worked for Wyeth, Pharmacopeia and Bristol-Myers Squibb. She received a bachelor’s degree in chemistry from Peking University and a Ph.D. in chemistry from Columbia University.

Ying Han

 Ms. Ying Han is Independent Director of WuXi PharmaTech (Cayman) Inc., since November 2008. From 1998 to 2006, Ms. Han worked for Asiainfo as Chief Financial Officer and Executive Vice President. Previously, she worked for 10 years at Hewlett Packard (China), where she was Chief Controller and Business Development Director. Since January 2011, she has served as an independent director of Netqin Mobile Inc., a NYSE-listed company. She is also currently an advisor to Warburg Pincus. Ms. Han received a bachelor’s degree in accounting from Xiamen University.

Stewart Hen

 Mr. Stewart J. Hen is Independent Director of WuXi PharmaTech (Cayman) Inc., since February 2009. Since August 2010, Mr. Hen has been Managing Partner of Serrado Capital LLC, a healthcare investment firm based in New York. Previously, he was a Managing Director at Warburg Pincus LLC where he focused on investments in biotechnology and pharmaceuticals. He has more than 18 years of experience in the life sciences industry. Prior to joining Warburg Pincus in 2000, he was a consultant at McKinsey & Company serving the pharmaceutical industry. From 1990 to 1994, he worked at Merck in both research and development and manufacturing. Mr. Hen received an MBA from the Wharton School of the University of Pennsylvania and a master’s degree in chemical engineering from the Massachusetts Institute of Technology.

Xuesong Leng

 Mr. Xuesong Leng is Independent Director of WuXi PharmaTech (Cayman) Inc., since October 2008. Mr. Leng joined General Atlantic LLC, a global growth investor, as Managing Director in 2007. From June 1999 to September 2007, he served as a Managing Director, Vice President and Associate at Warburg Pincus. Mr. Leng holds a bachelor’s degree from the business school of Jiao Tong University in Shanghai and an MBA from the Wharton School of the University of Pennsylvania.

Kian-Wee Seah

 Mr. Kian-Wee Seah is Independent Director of WuXi PharmaTech (Cayman) Inc., since 2005. Mr. Seah joined UOB Venture Management Pte. Ltd. in 1997 and currently holds the position of Managing Director. He chairs the investment committees of several private equity funds that focus on growth companies in China and ASEAN. He is a Chartered Financial Analyst. Mr. Seah received a bachelor’s degree in engineering from National University of Singapore, a master’s degree from the University of California at Los Angeles and an EMBA from Tsinghua University.

Ronald Aldridge

Basic Compensation

Name Fiscal Year Total

Ge Li

 --

Edward Hu

 --

Xiaozhong Liu

 --

Shuhui Chen

 --

Yifeng Shi

 --

Zhaohui Zhang

 --

Suhan Tang

 --

Ning Zhao

 --

Ying Han

 --

Stewart Hen

 --

Xuesong Leng

 --

Kian-Wee Seah

 --

Ronald Aldridge

 --
As Of 

Options Compensation

Name Options Value

Ge Li

 0 0

Edward Hu

 0 0

Xiaozhong Liu

 0 0

Shuhui Chen

 0 0

Yifeng Shi

 0 0

Zhaohui Zhang

 0 0

Suhan Tang

 0 0

Ning Zhao

 0 0

Ying Han

 0 0

Stewart Hen

 0 0

Xuesong Leng

 0 0

Kian-Wee Seah

 0 0

Ronald Aldridge

 0 0

Insider Trading

» Full list on Insider Trading
Search Stocks